Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors

Cited by (441)

Items 101–200 of 441

  1. Off‐target effects of engineered nucleases
    Jiing‐Kuan Yee · 2016 · FEBS Journal
  2. Epigenome engineering: new technologies for precision medicine
    Agustin Sgro, Pilar Blancafort · 2020 · Nucleic Acids Research
  3. Increasing the efficiency of CRISPR‐Cas9‐VQR precise genome editing in rice
    Xixun Hu, Xiangbing Meng, Qing Liu, Jiayang Li, Kejian Wang · 2017 · Plant Biotechnology Journal
  4. Non-canonical DNA/RNA structures during Transcription-Coupled Double-Strand Break Repair: Roadblocks or Bona fide repair intermediates?
    Nadine Puget, Kyle M. Miller, Gaëlle Legube · 2019 · DNA repair
  5. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
    Bashdar Mahmud Hussen, Mohammed Fatih Rasul, Snur Rasool Abdullah, Hazha Jamal Hidayat, Goran Sedeeq Hama Faraj, Fattma Abodi Ali, Abbas Burhan Salihi, Aria Baniahmad, Soudeh Ghafouri‐Fard, Milladur Rahman et al. · 2023 · Military Medical Research
  6. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
    Sándor Spisák, Kate Lawrenson, Yanfang Fu, István Csabai, Rebecca T. Cottman, Ji-Heui Seo, Christopher A. Haiman, Ying Han, Romina Lenci, Qiyuan Li et al. · 2015 · Nature Medicine
  7. CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries
    Florian Heigwer, Tianzuo Zhan, Marco Breinig, Jan Winter, Dirk Brügemann, Svenja Leible, Michael Boutros · 2016 · Genome biology
  8. Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
    Melissa L. Kelley, Žaklina Strezoska, Kaizhang He, Annaleen Vermeulen, Anja van Brabant Smith · 2016 · Journal of Biotechnology
  9. Cas9, Cpf1 and C2c1/2/3―What's next?
    Shota Nakade, Takashi Yamamoto, Tetsushi Sakuma · 2017 · Bioengineered
  10. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
    Maria Isabel G. Lopez Sanchez, Jonathan Guy Crowston, David Anthony Mackey, Ian Andrew Trounce · 2016 · Pharmacology & Therapeutics
  11. CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo
    Benjamin L. Duchêne, Khadija Cherif, Jean-Paul Iyombe-Engembe, Antoine Guyon, Joël Rousseau, Dominique L. Ouellet, Xavier Barbeau, Patrick Lagüe, Jacques P. Tremblay · 2018 · Molecular Therapy
  12. Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq
    Nikolay L. Malinin, GaHyun Lee, Cícera Regina Lazzarotto, Yichao Li, Zongli Zheng, Nathalie T. Nguyen, Matthew R. Liebers, Ved V. Topkar, Anthony John Iafrate, Long P. Le et al. · 2021 · Nature Protocols
  13. Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
    Jianli Tao, Qi Wang, Carlos Mendez‐Dorantes, Kathleen H. Burns, Roberto Chiarle · 2022 · Nature Communications
  14. Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9
    Wenjun Zhou, Yongjie Wan, Rihong Guo, Mingtian Deng, Kaiping Deng, Zhen Wang, Yanli Zhang, Feng Wang · 2017 · PLoS ONE
  15. Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
    Spencer C. Knight, Robert Tjian, Jennifer A. Doudna · 2017 · Angewandte Chemie International Edition
  16. iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity
    Christopher L. Nobles, Shantan G. Reddy, January Salas-McKee, Xiaojun Liu, Carl H. June, Jan Joseph Melenhorst, Megan M. Suhoski, Yangbing Zhao, Frederic D. Bushman · 2019 · Genome biology
  17. In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
    Jonathan M. Geisinger, Sören Turan, Sophia Hernandez, Laura P. Spector, Michèle P. Calos · 2016 · Nucleic Acids Research
  18. Deep learning improves the ability of sgRNA off-target propensity prediction
    Qiaoyue Liu, Xiang Cheng, Gan Liu, Bohao Li, Xiuqin Liu · 2020 · BMC Bioinformatics
  19. The therapeutic application of CRISPR/Cas9 technologies for HIV
    Sheena M. Saayman, Stuart Alvaro Ali, Kevin V. Morris, Marc S. Weinberg · 2015 · Expert Opinion on Biological Therapy
  20. Genome editing in crop improvement: Present scenario and future prospects
    Gurbachan S. Miglani · 2017 · Journal of Crop Improvement
  21. Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature
    Qiao Liu, Di He, Lei Xie · 2019 · PLoS Computational Biology
  22. Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics
    Lopes, Rui, Prasad, Megana K. · 2024 · Frontiers in Bioengineering and Biotechnology
  23. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs
    Matthew A. Coelho, Etienne D. Braekeleer, Mike A. Firth, Michał Biśta, Sebastian Łukasiak, Maria Emanuela Cuomo, Ben Taylor · 2020 · Nature Communications
  24. CRISPR system in filamentous fungi: Current achievements and future directions
    Huaxiang Deng, Ruijie Gao, Xiangru Liao, Yujie Cai · 2017 · Gene
  25. Use of CRISPR/Cas9 technology efficiently targetted goat myostatin through zygotes microinjection resulting in double-muscled phenotype in goats
    Zhengyi He, Ting Zhang, Lei Jiang, Minya Zhou, Daijin Wu, Junyan Mei, Yong Cheng · 2018 · Bioscience Reports
  26. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
    Bin Liu, Ali Saber, Hidde J. Haisma · 2019 · Drug Discovery Today
  27. CRISPR-Cas: A robust technology for enhancing consumer-preferred commercial traits in crops
    Vipasha Verma, Akhil Kumar, Mahinder Partap, Meenakshi Thakur, Bhavya Bhargava · 2023 · Frontiers in Plant Science
  28. Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
    Jean-Paul Iyombe-Engembe, Dominique L. Ouellet, Xavier Barbeau, Joël Rousseau, Pierre Chapdelaine, Patrick Lagüe, Jacques P. Tremblay · 2016 · Molecular Therapy — Nucleic Acids
  29. A fast and reliable strategy to generate TALEN-mediated gene knockouts in the diatom Phaeodactylum tricornutum
    Manuel Serif, Lepetit Bernard, Kristoffer Weißert, Peter G. Kroth, Carolina Río Bártulos · 2017 · Algal Research
  30. Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
    Andrew Atkins, Cheng-Han Chung, Alexander G. Allen, Will Dampier, Theodore E. Gurrola, Ilker Kudret Sariyer, Michael R. Nonnemacher, Brian L. Wigdahl · 2021 · Frontiers in Genome Editing
  31. CRISPR-Cas9 technology: applications and human disease modelling
    Raúl Torres-Ruiz, Sandra Rodríguez · 2016 · Briefings in Functional Genomics
  32. Efficient Generation of Gene-Modified Pigs Harboring Precise Orthologous Human Mutation via CRISPR/Cas9-Induced Homology-Directed Repair in Zygotes
    Xiaoyang Zhou, Lulu Wang, Yinan Du, Fei Xie, Liang Li, Yu Liu, Chuanhong Liu, Shi‐Qiang Wang, Shi‐Bing Zhang, Xingxu Huang et al. · 2015 · Human Mutation
  33. Distinct patterns of Cas9 mismatch tolerancein vitroandin vivo
    Becky Xu Hua Fu, Robert P. St.Onge, Andrew Z. Fire, Justin Smith · 2016 · Nucleic Acids Research
  34. TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation
    Ferri, Federica, Parcelier, Aude, Petit, Vanessa, Gallouet, Anne-Sophie, Lewandowski, Daniel, Dalloz, Marion, van den Heuvel, Anita, Kolovos, Petros, Soler, Eric, Squadrito, Mario Leonardo et al. · 2015 · Nature Communications
  35. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus
    Buhle Moyo, Kristie M. Bloom, Tristan A. Scott, Abdullah Ely, Patrick B. Arbuthnot · 2017 · Virus Research
  36. Critical roles of αII spectrin in brain development and epileptic encephalopathy
    Yu Wang, Tuo Ji, Andrew D. Nelson, Katarzyna M. Glanowska, Geoffrey G. Murphy, Paul M. Jenkins, Jack M. Parent · 2018 · Journal of Clinical Investigation
  37. Towards a new era in medicine: therapeutic genome editing
    Porteus, Matthew H. · 2015 · Genome Biology
  38. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
    Akbar Hasanzadeh, Michael Richard Hamblin, Jafar Kiani, Hamid Noori, Joseph Michael Hardie, Mahdi Karimi, Hadi Shafiee · 2022 · Nano Today
  39. Fine-Tuning Next-Generation Genome Editing Tools
    Chidananda Nagamangala Kanchiswamy, Massimo Emilio Maffei, Mickaël Malnoy, Riccardo Velasco, Jin‐Soo Kim · 2016 · Trends in biotechnology
  40. Guidelines for Optimized Gene Knockout Using CRISPR/Cas9
    Claude Van Campenhout, Pauline Cabochette, Anne-Clémence Veillard, Miklós Laczik, Agnieszka Zelisko-Schmidt, Céline Sabatel, Maxime Dhainaut, Benoît Vanhollebeke, Cyril Gueydan, Véronique Kruys · 2019 · BioTechniques
  41. Expression of CRISPR/Cas single guide RNAs using small tRNA promoters
    Adam L. Mefferd, Anand V. R. Kornepati, Hal P. Bogerd, Edward M. Kennedy, Bryan R. Cullen · 2015 · RNA
  42. Designed nucleases for targeted genome editing
    Junwon Lee, Jae‐Hee Chung, Ho Min Kim, Seokjoong Kim, Seokjoong Kim · 2015 · Plant Biotechnology Journal
  43. The genome editing revolution: A CRISPR‐Cas TALE off‐target story
    Stefano Stella, Guillermo Montoya · 2016 · BioEssays
  44. Fluorescent protein tagging of endogenous protein in brain neurons using CRISPR/Cas9-mediated knock-in and in utero electroporation techniques
    Takeshi Uemura, Takuma Mori, Taiga Kurihara, Shiori Kawase, Rie Koike, Michiru Satoga, Xueshan Cao, Xue Li, Toru Yanagawa, Takayuki Sakurai et al. · 2016 · Scientific Reports
  45. CRISPR–Cas9-mediated genome editing and guide RNA design
    Michael V. Wiles, Wenning Qin, Albert W. Cheng, Haoyi Wang · 2015 · Mammalian Genome
  46. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and PiggyBac transposase lineage labeling
    Fuyi Chen, Joel A. Rosiene, Alicia Che, Albert J. Becker, Joseph J. LoTurco · 2015 · Development
  47. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Maximilian Haeussler, Jean‐Paul Concordet · 2016 · Journal of genetics and genomics/Journal of Genetics and Genomics
  48. Use of TALEs and TALEN Technology for Genetic Improvement of Plants
    Zulqurnain Khan, Sultan Habibullah Khan, Muhammad Salman Mubarik, Bushra Sadia, Aftab Ahmad · 2016 · Plant Molecular Biology Reporter
  49. CRISPR system: Discovery, development and off-target detection
    Chen, Shengmiao, Yao, Yufeng, Zhang, Yanchun, Fan, Gaofeng · 2020 · Cellular Signalling
  50. CRISPR/Cas9, a powerful tool to target human herpesviruses
    Ferdy R. van Diemen, Robert Jan Lebbink · 2016 · Cellular Microbiology
  51. Lipid- and polymer-based nanoparticle systems for the delivery of CRISPR/Cas9
    Bhaargavi Ashok, Nicholas A. Peppas, Marissa E. Wechsler · 2021 · Journal of Drug Delivery Science and Technology
  52. The Role of Recombinant AAV in Precise Genome Editing
    Swati Bijlani, Ka Ming Pang, Venkatesh Sivanandam, Amanpreet Singh, Saswati Chatterjee · 2022 · Frontiers in Genome Editing
  53. ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
    Camilo Ayala Breton, Peter Clark, Lili Wang, Jenny A. Greig, James M. Wilson · 2020 · BMC Genomics
  54. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
    Nivya Kolli, Ming Lü, Panchanan Maiti, Julien Rossignol, Gary Leo Dunbar · 2017 · Neurochemistry International
  55. Prediction of CRISPR/Cas9 single guide RNA cleavage efficiency and specificity by attention-based convolutional neural networks
    Guishan Zhang, Tian Zeng, Zhiming Dai, Xianhua Dai · 2021 · Computational and Structural Biotechnology Journal
  56. Computational Tools and Resources Supporting CRISPR-Cas Experiments
    Paweł Śledziński, Mateusz Nowaczyk, Marta Olejniczak · 2020 · Cells
  57. Endogenous DNA Double-Strand Breaks during DNA Transactions: Emerging Insights and Methods for Genome-Wide Profiling
    Britta A. M. Bouwman, Nicola Crosetto · 2018 · Genes
  58. END-seq: An Unbiased, High-Resolution, and Genome-Wide Approach to Map DNA Double-Strand Breaks and Resection in Human Cells
    Nancy Wong, Sam John, André Nussenzweig, Andrés Canela · 2020 · Methods in molecular biology
  59. CRISPR/Cas9: a tool to eradicate HIV-1
    Ruchira Bhowmik, Binay Chaubey · 2022 · AIDS Research and Therapy
  60. Transitioning from wet lab to artificial intelligence: a systematic review of AI predictors in CRISPR
    Ahtisham Fazeel Abbasi, Muhammad Nabeel Asim, Andreas Dengel · 2025 · Journal of Translational Medicine
  61. Recognition of CRISPR/Cas9 off-target sites through ensemble learning of uneven mismatch distributions
    Hui Peng, Yi Zheng, Zhixun Zhao, Tao Liu, Jinyan Li · 2018 · Bioinformatics
  62. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration
    Baohong Luo, Yikang Zhan, Minqi Luo, Huimin Dong, Jun Liu, Yingtong Lin, Junsong Zhang, Guanwen Wang, Els Verhoeyen, Yiwen Zhang et al. · 2020 · Cell Death and Disease
  63. Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.
    Adam P. Cribbs, Sumeth Perera · 2017 · PubMed
  64. Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
    Giulia Pavani, Marine Laurent, Anna Fabiano, Erika Cantelli, Aboud Sakkal, Guillaume Corre, Peter J. Lenting, Jean‐Paul Concordet, Magali Toueille, Annarita Miccio et al. · 2020 · Nature Communications
  65. Concerns regarding ‘off-target’activity of genome editing endonucleases
    Kadam, Ulhas Sopanrao, Shelake, Rahul Mahadev, Chavhan, Rahul L., Suprasanna, Penna · 2018 · Plant Physiology and Biochemistry
  66. From Gene Targeting to Genome Editing: Transgenic animals applications and beyond
    Maurício Rocha-Martins, Gabriel R. Cavalheiro, Gabriel E. Matos-Rodrigues, Rodrigo A. P. Martins · 2015 · Anais da Academia Brasileira de Ciências
  67. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus
    Alejandra Gutiérrez-Guerrero, Sabina Sánchez-Hernández, Giuseppe Galvani, Javier Pinedo-Gomez, Rocío Martín-Guerra, Almudena Sánchez‐Gilabert, Araceli Aguilar-González, Marién Cobo, Philip D. Gregory, Michael C. Holmes et al. · 2017 · Human Gene Therapy
  68. Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues
    Christin Luft, Robin Ketteler · 2015 · SLAS DISCOVERY
  69. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
    Sandy S. C. Hung, Tristan McCaughey, Olivia G. Swann, Alice Pébay, Alex William Hewitt · 2016 · Progress in Retinal and Eye Research
  70. CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
    Bilal Ahmad Lone, Shibendra Kumar Lal Karna, Faiz Ahmad, Nerina Shahi, Yuba Raj Pokharel · 2018 · Genetics Research International
  71. A modular open platform for systematic functional studies under physiological conditions
    Christopher B. Mulholland, Martha Smets, Elisabeth Schmidtmann, Susanne Leidescher, Yolanda Markaki, Mario Hofweber, Weihua Qin, Massimiliano Manzo, Elisabeth Kremmer, Katharina Thanisch et al. · 2015 · Nucleic Acids Research
  72. Variability in Genome Editing Outcomes: Challenges for Research Reproducibility and Clinical Safety
    Lydia Teboul, Yann Hérault, Sara E. Wells, Waseem Qasim, Guillaume Pavlovic · 2020 · Molecular Therapy
  73. Technologies and Computational Analysis Strategies for CRISPR Applications
    Kendell Clement, Jonathan Y. Hsu, Matthew C. Canver, J. Keith Joung, Luca Pinello · 2020 · Molecular Cell
  74. TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor
    Jeonghun Kwon, Minyoung Kim, Seung-Min Bae, Anna Jo, Young-Ho Kim, Jungjoon K. Lee · 2022 · Nature Communications
  75. Shape selective bifacial recognition of double helical DNA
    Shivaji A. Thadke, V. M. Hridya, J. Dinithi R. Perera, Roberto R. Gil, Arnab Mukherjee, Danith H. Ly · 2018 · Communications Chemistry
  76. Genome-wide detection of DNA double-strand breaks by in-suspension BLISS
    Britta A. M. Bouwman, Federico Agostini, Silvano Garnerone, Giuseppe Petrosino, Henrike Johanna Gothe, Sergi Sayols, Andreas E. Moor, Shalev Itzkovitz, Magda Bienko, Vassilis Roukos et al. · 2020 · Nature Protocols
  77. Genome editing in potato plants by agrobacterium-mediated transient expression of transcription activator-like effector nucleases
    Jin Ma, Heng Xiang, Danielle J. Donnelly, Fanrui Meng, Huimin Xu, Dion G. Durnford, Xiu‐Qing Li · 2017 · Plant Biotechnology Reports
  78. Synergizing Off-Target Predictions for In Silico Insights of CENH3 Knockout in Cannabis through CRISPR/Cas
    Mohsen Hesami, Mohsen Yoosefzadeh-Najafabadi, Kristian Adamek, Davoud Torkamaneh, Andrew Maxwell Phineas Jones · 2021 · Molecules
  79. Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
    Jakob M. Domm, Sarah K. Wootton, Jeffrey A. Medin, Michael L. West · 2021 · Molecular Genetics and Metabolism
  80. Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
    Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, Najmeh Heshmatpour, Sarita R. Patnaik · 2024 · Frontiers in Genome Editing
  81. Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
    Kentaro Ishida, Peter Gee, Akitsu Hotta · 2015 · International Journal of Molecular Sciences
  82. Keeping CRISPR/Cas on-Target
    Muhammad Jamal, Faheem Ahmed Khan, Da Lin, Zeshan Habib, Jinxia Dai, Gang Cao · 2016 · Current Issues in Molecular Biology
  83. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
    Lihua Julie Zhu, Michael Lawrence, Ankit Gupta, Hervé Pagès, Alper Küçükural, Manuel G. Garber, Scot A. Wolfe · 2017 · BMC Genomics
  84. The AAV-mediated and RNA-guided CRISPR/Cas9 system for gene therapy of DMD and BMD
    Wang, Jing-Zhang, Wu, Peng, Shi, Zhi-Min, Xu, Yan-Li, Liu, Zhi-Jun · 2017 · Brain and Development
  85. CRISPRoffT: comprehensive database of CRISPR/Cas off-targets
    Grant Wang, Xiaona Liu, Aoqi Wang, Jianguo Wen, Pora Kim, Qianqian Song, Xiaona Liu, Xiaobo Zhou · 2024 · Nucleic Acids Research
  86. Mapping the precision of genome editing
    Richard Gabriel, Christof V. Kalle, Manfred Schmidt · 2015 · Nature Biotechnology
  87. CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
    Wanshun Wen, Zhi‐Min Yuan, Shijie Ma, Xu Jiang, Dongtang Yuan · 2015 · International Journal of Cancer
  88. CRISPR/Cas9 editing of the genome for cancer modeling
    Alexis A. Guernet, Luca Grumolato · 2017 · Methods
  89. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin
    Zhichang Zhang, Chun Yan Tang, Yang Dong, Jing Zhang, Ting Yuan, Xiaolin Li · 2017 · Journal of Cancer
  90. Yeast genetic interaction screens in the age of CRISPR/Cas
    Neil R. Adames, Jenna E. Gallegos, Jean Peccoud · 2018 · Current Genetics
  91. Identifying genome-wide off-target sites of CRISPR RNA–guided nucleases and deaminases with Digenome-seq
    Daesik Kim, Beum‐Chang Kang, Jin‐Soo Kim · 2021 · Nature Protocols
  92. Recent Advancements in DNA Damage–Transcription Crosstalk and High-Resolution Mapping of DNA Breaks
    Valerio Vitelli, Alessandro Galbiati, Fabio Iannelli, Fabio Pessina, Sheetal Sharma, Fabrizio d’Adda di Fagagna · 2017 · Annual Review of Genomics and Human Genetics
  93. Paving the way towards precise and safe CRISPR genome editing
    Paweł Śledziński, Magdalena Dabrowska, Mateusz Nowaczyk, Marta Olejniczak · 2021 · Biotechnology Advances
  94. Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
    Friederike Knipping, Mark J. Osborn, Karl Petri, Jakub Tolar, Hanno Glimm, Christof V. Kalle, Manfred Schmidt, Richard Gabriel · 2017 · Molecular Therapy — Methods & Clinical Development
  95. Precision digital mapping of endogenous and induced genomic DNA breaks by INDUCE-seq
    Felix M. Dobbs, Patrick van Eijk, Mick D. Fellows, Luisa Loiacono, Roberto Nitsch, Simon Huw Reed · 2022 · Nature Communications
  96. CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
    Prashant Kumar Tiwari, Tin-Hsien Ko, Rajni Dubey, Mandeep Chouhan, Lung-Wen Tsai, Himanshu Narayan Singh, Kundan Kumar Chaubey, Deen Dayal, Chih‐Wei Chiang, Sanjay Kumar · 2023 · Frontiers in Molecular Biosciences
  97. Allele-specific genome targeting in the development of precision medicine
    Junjiao Wu, Beisha Tang, Yu Tang · 2020 · Theranostics
  98. Exome sequencing in the knockin mice generated using the CRISPR/Cas system
    Kazuo Nakajima, An‐a Kazuno, John R. Kelsoe, Moe Nakanishi, Toru Takumi, Tadafumi Kato · 2016 · Scientific Reports
  99. Synergizing CRISPR/Cas9 off-target predictions for ensemble insights and practical applications
    Shixiong Zhang, Xiangtao Li, Qiuzhen Lin, Ka‐Chun Wong · 2018 · Bioinformatics
  100. crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays
    Störtz, Florian, Minary, Peter · 2021 · Nucleic Acids Research